PSA Test Controversy: Does a High PSA Really Mean You Have Prostate Cancer?
What is the PSA Test, and Who Invented It?
The PSA (Prostate-Specific Antigen) test is a blood test that measures the level of PSA, a protein produced by the prostate gland. The test was developed in the 1970s by Dr. Richard J. Ablin, who initially believed it would help monitor patients with prostate cancer, not diagnose it.
However, it became widely used as a screening tool, even though Dr. Ablin has since argued that it should not be used as the sole indicator of prostate cancer.
Does the PSA Test Prove Prostate Cancer?
No, the PSA test does not definitively prove that someone has prostate cancer. High PSA levels can result from several non-cancerous conditions, including an enlarged prostate (benign prostatic hyperplasia), inflammation (prostatitis), or even a urinary infection.
Thus, an elevated PSA level is not necessarily a sign of cancer but indicates that more evaluation might be necessary .
Why is the PSA Test No Longer Considered as Accurate?
Several reasons have contributed to the reevaluation of the PSA test's accuracy:
• Overdiagnosis and Overtreatment: Studies show that PSA testing can lead to overdiagnosis of prostate cancers that may never cause harm. Many detected cancers are low-risk and may grow so slowly that they wouldn't affect health during a man's lifetime .
• False Positives and False Negatives: High PSA levels can be triggered by various non-cancerous conditions, causing unnecessary worry and additional testing. Similarly, low PSA levels might miss aggressive cancers, giving a false sense of security.
• Age and Ethnic Variability: PSA levels naturally increase with age, and the “normal” levels can vary significantly based on factors like age and ethnicity, making a single threshold hard to apply to everyone .
• Limited Impact on Mortality: Large-scale studies, like the CAP Randomized Clinical Trial, found only a minimal effect on reducing prostate cancer mortality. This means that while the PSA test detects cancer, it doesn't necessarily save lives.
Which Countries Are No Longer Recommending the PSA Test?
Many high-income countries no longer recommend routine PSA testing for all men. The United Kingdom, for example, does not offer it as part of a national screening program. Instead, men are advised to discuss it with their doctors to make an informed decision.
Similarly, the United States Preventive Services Task Force suggests PSA screening only for men aged 55-69, and even then, only after discussing the risks and benefits with their healthcare provider.
What Should a Man Do Instead of the PSA Test?
Men concerned about prostate health are encouraged to consider other options:
• Informed Decision-Making: Discussing options with a healthcare provider can help assess individual risk factors, including family history and lifestyle.
• MRI Scans: In cases where cancer is suspected, an MRI can offer a more accurate view and is often used to help avoid unnecessary biopsies
• Regular Health Monitoring: Instead of routine PSA tests, many experts now recommend watching for symptoms or changes and having regular checkups to monitor prostate health.
The Prostate Cancer Warrior's Hopeful Conclusion:
It's natural for a high PSA result to be alarming, but it does not mean that a man has prostate cancer or that his life is in immediate danger. Many prostate cancers grow so slowly that they will never pose a threat.
Advancements in monitoring and newer tests are making it easier to catch aggressive cancers while avoiding unnecessary treatments for those that are not life-threatening. For men with concerns, the best approach is an informed, balanced conversation with a doctor.
Understanding your options and the true meaning behind a PSA test result can bring relief and clarity, offering a way forward that prioritizes both health and peace of mind.
Scott Oliver, 66, is living well with prostate cancer after dedicating more than 4,000 hours to researching the condition. His first goal is to help men reduce their risk of developing prostate cancer through proven lifestyle strategies.
When diagnosed, his mission is to help men avoid unnecessary prostate surgeries that can lead to devastating complications such as incontinence, bleeding, permanent impotence, and a loss of length.
Scott Oliver is not a doctor and does not offer medical advice; however, he is healthier and fitter than he has been in decades. Through his articles and videos, he shares hard-to-find, uncensored information on proven alternative therapies, effective fitness methods, and repurposed drugs, content that most doctors won’t mention and search engines suppress.
He is an accredited member of the National Writers Union (NWU) and the International Federation of Journalists (IFJ), the world’s largest organization of professional journalists. Scott is also the author of What If Cancer’s Best Defense Is Free? Sleep as a Defense Against Cancer: A Former Royal Marines Commando’s 4,000-Hour Research Roadmap, where he reveals how sleep repairs DNA, restores immunity, and strengthens the body’s natural defenses against cancer.
You can always contact Scott Oliver here with your questions and suggestions.
About the Author
Expert Resources Use To Write This Article.
Here are several expert articles and papers that question the PSA test's accuracy and validity, especially in routine screening for prostate cancer. These resources highlight concerns about the test's potential for false positives, unnecessary treatments, and limited impact on mortality rates:
1. “Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline” – Published by The BMJ, this article discusses how PSA screening has led to many men being treated for cancers that might not have caused harm, raising concerns about overdiagnosis. https://www.bmj.com/content/362/bmj.k3581
2. “New study once again casts doubt on PSA screening” – Harvard Health summarizes a large study of over 400,000 men which found that PSA screening did not significantly reduce prostate cancer death rates, suggesting limited benefits in population-based screening. https://www.health.harvard.edu/blog/new-study-once-again-casts-doubt-on-psa-screening-2018040613526
3. “Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality” – Published by JAMA Network, this analysis of a large randomized trial reports that PSA screening led to increased diagnoses but only a marginal reduction in mortality, raising questions about its overall effectiveness in preventing deaths. https://jamanetwork.com/journals/jamaoncology/fullarticle/2685978
4. “A discussion on controversies and ethical dilemmas in prostate cancer screening” – In this Journal of Medical Ethics article, experts discuss PSA's limitations, noting that elevated PSA levels can result from various benign conditions, leading to a high rate of false positives and unnecessary biopsies. https://jme.bmj.com/content/44/4/269
5. “Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline” – This BMJ article covers the controversies surrounding PSA screening, highlighting concerns about overdiagnosis and treatment for cancers that may not have been life-threatening. https://www.bmj.com/content/362/bmj.k3581
6. “Less prostate cancer screening reduces overdiagnosis but may miss aggressive cases” – ScienceDaily discusses research from Weill Cornell Medicine on the limitations of PSA screening, including the risk of overtreatment. https://www.sciencedaily.com/releases/2022/04/220422114745.htm
7. “Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit” – This BMJ article argues that the PSA test's minimal impact on mortality rates has led to a shift in screening policies across many countries. https://www.bmj.com/content/381/bmj-2022-071082